Brief: Beyond Air Enters Definitive Agreement To Sell Its NeuroNOS Stake To UNIVO Pharmaceutical Industries In Exchange For Equity And Milestone Payments
25/08/2026 12:42
BRIEF-Beyond Air Enters Definitive Agreement To Sell Its NeuroNOS Stake To UNIVO Pharmaceutical Industries In Exchange For Equity And Milestone Payments Aug 25 (Reuters) - Beyond Air Inc XAIR.O:
BEYOND AIR ENTERS DEFINITIVE AGREEMENT TO SELL ITS NEURONOS STAKE TO UNIVO PHARMACEUTICAL INDUSTRIES IN EXCHANGE FOR EQUITY AND MILESTONE PAYMENTS
BEYOND AIR - TO RECEIVE 19.99% OF UNIVO SHARE CAPITAL UPON CLOSING
BEYOND AIR - ELIGIBLE FOR UP TO $32.50 MILLION IN MILESTONE PAYMENTS
BEYOND AIR - TO TRANSFER IP TO NEURONOS FOR UP TO $6.50 MILLION DEVELOPMENT MILESTONES
BEYOND AIR - ELIGIBLE FOR UP TO $26 MILLION IN COMMERCIAL MILESTONE PAYMENTS
Source text: ID:nGNXty1JV
Further company coverage: XAIR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beyond Air
See all newsBrief: Beyond Air Enters Definitive Agreement To Sell Its NeuroNOS Stake To UNIVO Pharmaceutical Industries In Exchange For Equity And Milestone Payments
Beyond Air Inc reports results for the quarter ended June 30 - Earnings Summary
Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlook
Beyond Air Inc expected to post a loss of $10.80 a share - Earnings Preview
NASDAQ RESUMED AT 04:00 AM